Your browser doesn't support javascript.
loading
Efficacy on the risk of vertebral fracture with administration of once-weekly 17.5 mg risedronate in Japanese patients of established osteoporosis with prevalent vertebral fractures: a 156-week longitudinal observational study in daily practice.
Soen, Satoshi; Umemura, Takashi; Ando, Tsuyoshi; Kamisaki, Toshiaki; Nishikawa, Masahiko; Muraoka, Ryoichi; Ikeda, Yoshinori; Takeda, Kyoko; Osawa, Mitsuharu; Nakamura, Toshitaka.
Afiliação
  • Soen S; Department of Orthopaedic Surgery and Rheumatology, Nara Hospital, Kindai University Faculty of Medicine, 1248-1 Otodacho, Ikoma, Nara, 630-0293, Japan.
  • Umemura T; Post-marketing Medical Research Department, Ajinomoto Pharmaceuticals Co., Ltd., 1-1 Irifune 2-Chome, Chuo-ku, Tokyo, 104-0042, Japan. takashi_umemura@eapharma.co.jp.
  • Ando T; Post-marketing Medical Research Department, Ajinomoto Pharmaceuticals Co., Ltd., 1-1 Irifune 2-Chome, Chuo-ku, Tokyo, 104-0042, Japan.
  • Kamisaki T; Post-marketing Medical Research Department, Ajinomoto Pharmaceuticals Co., Ltd., 1-1 Irifune 2-Chome, Chuo-ku, Tokyo, 104-0042, Japan.
  • Nishikawa M; Post-marketing Medical Research Department, Ajinomoto Pharmaceuticals Co., Ltd., 1-1 Irifune 2-Chome, Chuo-ku, Tokyo, 104-0042, Japan.
  • Muraoka R; Data Science Group, Clinical Development Department, Ajinomoto Pharmaceuticals Co., Ltd., 1-1 Irifune 2-Chome, Chuo-ku, Tokyo, 104-0042, Japan.
  • Ikeda Y; Post-marketing Surveillance Group, Pharmacovigilance Department, Japan Development Center, Takeda Pharmaceutical Co., Ltd., 1-1 Doshomachi 4-Chome, Chuo-ku, Osaka, 540-8645, Japan.
  • Takeda K; Post-marketing Surveillance Group, Pharmacovigilance Department, Japan Development Center, Takeda Pharmaceutical Co., Ltd., 1-1 Doshomachi 4-Chome, Chuo-ku, Osaka, 540-8645, Japan.
  • Osawa M; Drug Fostering and Evolution Coordination Department, Corporate Medical Affairs, Eisai Co., Ltd., 6-10 Koishikawa 4-Chome, Bunkyo-ku, Tokyo, 112-8088, Japan.
  • Nakamura T; National Center for Global Health and Medicine, 21-1 Toyama 1-Chome, Shinjuku-ku, Tokyo, 162-8655, Japan.
J Bone Miner Metab ; 35(4): 419-427, 2017 Jul.
Article em En | MEDLINE | ID: mdl-27565972
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Fraturas da Coluna Vertebral / Povo Asiático / Ácido Risedrônico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: J Bone Miner Metab Assunto da revista: METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Fraturas da Coluna Vertebral / Povo Asiático / Ácido Risedrônico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: J Bone Miner Metab Assunto da revista: METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão